Philips recalled 285 CT systems on August 13, 2025, due to a risk of patient support tables descending unexpectedly. The recall affects model numbers 728321, 728323, and 728326. Users should stop using the devices immediately and follow manufacturer instructions.
The patient support table (couch) may descend unexpectedly to the lowermost position due to a component (ball screw) misalignment after a replacement.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Philips North America Llc or your healthcare provider for instructions. Notification method: Letter
The recall includes Philips Ingenuity CT systems, specifically model numbers 728321, 728323, and 728326. The devices were distributed worldwide, including in the United States and several countries across Europe, Asia, and South America.
The patient support table may descend unexpectedly to the lowermost position due to a misalignment of a component known as the ball screw. This situation poses a high hazard level, potentially leading to serious injury.
There have been no specific reports of injuries associated with this recall. Philips issued this recall proactively after identifying the potential risk.
Stop using the affected devices immediately. Contact Philips North America or your healthcare provider for further instructions regarding the recall.
For more information, contact Philips North America at 1-800-xxx-xxxx or visit the recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2600-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.